- 专利标题： Compound for treating or preventing hyperuricemia or gout
-
申请号： US15758866申请日： 2016-09-08
-
公开(公告)号： US10399971B2公开(公告)日： 2019-09-03
- 发明人: Dongfang Shi , Changjin Fu , Xi Cheng , Jianghua Zhu , Jie Wen , Jie Gu
- 申请人： JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD.
- 申请人地址： CN Zhenjiang
- 专利权人： JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD.
- 当前专利权人： JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD.
- 当前专利权人地址： CN Zhenjiang
- 代理机构： CBM Patent Counsulting, LLC
- 优先权： CN201510576110 20150910
- 国际申请： PCT/CN2016/098468 WO 20160908
- 国际公布： WO2017/041732 WO 20170316
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/437 ; A61P19/06
摘要：
The invention discloses a class of compounds for treating or preventing hyperuricemia or gout, which is a compound shown in general formula (I) or a pharmaceutically acceptable salt. These compounds and their pharmaceutically acceptable salts in the invention are useful for the promotion of uric acid excretion to treat or prevent hyperuricemia or gout.
公开/授权文献
信息查询
